Quantum Biopharma (QNTM) Investment Income (2025 - 2026)
Quantum Biopharma's (QNTM) quarterly Investment Income came in at $906364.0 in Q2 2026, up 199.21% year-over-year from $302923.8 in Q2 2025, and up 199.21% quarter-over-quarter from -$913625.0 in Q2 2025.
Powered by 
Analysis
Quantum Biopharma (QNTM) Investment Income (2025 - 2026) Analysis & Trends
Quantum Biopharma has disclosed Investment Income across 2 years of filings, most recently posting $906364.0 for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Quantum Biopharma | 11.80 Mn | 8.15 Mn | - | 906,364.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 906,364.00 |
| Jun 30, 2025 | -913,625.00 |